Potential for myeloablation with yttrium-90-labeled HuM195 (anti-CD33): A phase I trial in advanced myeloid leukemias Meeting Abstract


Authors: Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Ma, D.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
Abstract Title: Potential for myeloablation with yttrium-90-labeled HuM195 (anti-CD33): A phase I trial in advanced myeloid leukemias
Meeting Title: 40th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 92
Issue: 10 Suppl. 1 Pt. 1
Meeting Dates: 1998 Dec 4-8
Meeting Location: Miami Beach, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 1998-11-15
Start Page: 613a
Language: English
ACCESSION: WOS:000077121302515
PROVIDER: wos
PUBMED: 9835841
Notes: Meeting Abstract: 2528 -- Source: Wos
MSK Authors
  1. George Sgouros
    122 Sgouros
  2. Chaitanya Divgi
    114 Divgi
  3. Ronald D Finn
    244 Finn
  4. Michael R Mcdevitt
    118 Mcdevitt
  5. Dangshe Ma
    21 Ma
  6. Joseph G Jurcic
    126 Jurcic
  7. Steven M Larson
    742 Larson